RAPTOR PHARMACEUTICAL CORP's ticker is and the CUSIP is 75382F956. A total of 3 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,536,000 | +128.9% | 617,200 | +37.0% | 0.06% | +106.9% |
| Q2 2016 | $2,419,000 | +14.5% | 450,400 | -1.9% | 0.03% | -3.3% |
| Q1 2016 | $2,112,000 | -65.4% | 459,100 | -60.8% | 0.03% | -58.3% |
| Q4 2015 | $6,097,000 | -35.2% | 1,172,500 | -24.6% | 0.07% | -44.6% |
| Q3 2015 | $9,411,000 | -77.0% | 1,555,500 | -40.0% | 0.13% | -77.3% |
| Q2 2015 | $40,943,000 | +88.1% | 2,593,000 | +29.5% | 0.57% | +67.5% |
| Q1 2015 | $21,770,000 | +122.2% | 2,002,800 | +115.0% | 0.34% | +131.1% |
| Q4 2014 | $9,799,000 | +52.0% | 931,500 | +38.6% | 0.15% | +49.5% |
| Q3 2014 | $6,445,000 | -48.0% | 672,100 | -37.4% | 0.10% | -48.2% |
| Q2 2014 | $12,395,000 | +30.1% | 1,073,200 | +12.7% | 0.19% | +19.4% |
| Q1 2014 | $9,525,000 | +134.5% | 952,500 | +205.4% | 0.16% | +162.3% |
| Q4 2013 | $4,061,000 | +694.7% | 311,900 | +812.0% | 0.06% | +510.0% |
| Q3 2013 | $511,000 | +25.2% | 34,200 | -21.6% | 0.01% | 0.0% |
| Q2 2013 | $408,000 | – | 43,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 931,500 | $9,799,000 | 0.15% |
| SIMPLEX TRADING, LLC | 626 | $76,000 | 0.01% |
| Citadel Advisors | 23,100 | $243,000 | 0.00% |